Fatal leukemia in interleukin-15 transgenic mice

被引:36
|
作者
Fehniger, TA
Suzuki, K
VanDeusen, JB
Cooper, MA
Freud, AG
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Comphrehens Canc Ctr, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma, Japan
关键词
D O I
10.1006/bcmd.2001.0379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of inflammation in the early genesis of certain malignancies has recently been appreciated. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms, suggesting that inappropriate expression of IL-15 may be detrimental to the host. We recently engineered a transgenic mouse in which the normal posttranscriptional control of IL-15 is eliminated, thereby overexpressing the murine IL-15 protein. IL-15 transgenic mice have early expansions in NK and CD8(+) T lymphocytes and later develop fatal lymphocytic leukemia with a T-NK phenotype. This article recapitulates the phenotype of these IL-15 transgenic mice and discusses the utility of this model as a tool to further our understanding of leukemogenesis. (C) 2001 Academic Press.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [41] Interleukin-2 and interleukin-15: immunotherapy for cancer
    Fehniger, TA
    Cooper, MA
    Caligiuri, MA
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 169 - 183
  • [42] Interleukin-15: A critical player in neuroinflammation
    Pan Weihong
    Hsuchou Hong
    Yu Chuanhui
    Zhang Yan
    Wu Xiaojun
    He Yi
    Kastin, Abba J.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 145 - 145
  • [43] PRODUCTION OF INTERLEUKIN-15 BY HUMAN KERATINOCYTES
    SOREL, M
    CHEREL, M
    DRENO, B
    BOUYGE, I
    GUILBERT, J
    DUBOIS, S
    MINVIELLE, S
    JACQUES, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) : 463 - 463
  • [44] Interleukin-15 and the regulation of lymphoid homeostasis
    Lodolce, J
    Burkett, P
    Koka, R
    Boone, D
    Chien, M
    Chan, F
    Madonia, M
    Chai, S
    Ma, A
    MOLECULAR IMMUNOLOGY, 2002, 39 (09) : 537 - 544
  • [45] Interleukin-15 expression in lung cancer
    Adhami, Faisal
    Steel, Jason C.
    Morris, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Circulating interleukin-15 in dementia disorders
    Rentzos, Michael
    Paraskevas, George P.
    Kapaki, Elisabeth
    Nikolaou, Chryssoula
    Zoga, Margarita
    Tsoutsou, Anthousa
    Rombos, Antonis
    Vassilopoulos, Demetrios
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 19 (03) : 318 - 325
  • [47] Interleukin-15 promotes angiogenesis in vivo
    Angiolillo, AL
    Kanegane, H
    Sgadari, C
    Reaman, GH
    Tosato, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) : 231 - 237
  • [48] Regulation of lymphoid homeostasis by interleukin-15
    Lodolce, JP
    Burkett, PR
    Koka, RM
    Boone, DL
    Ma, A
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (06) : 429 - 439
  • [49] Interleukin-15 in Gene Therapy of Cancer
    Ochoa, Maria C.
    Mazzolini, Guillermo
    Hervas-Stubbs, Sandra
    de Sanmamed, Miguel F.
    Berraondo, Pedro
    Melero, Ignacio
    CURRENT GENE THERAPY, 2013, 13 (01) : 15 - 30
  • [50] High bone mass and decreased osteoclastogenesis in mice null for interleukin-15 receptor
    Ferrari-Lacraz, S.
    Djaafar, S.
    Pierroz, D.
    Ferrari, S. L.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S30 - S31